Status:
ENROLLING_BY_INVITATION
Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy Project
Lead Sponsor:
IMDEA Food
Conditions:
Obesity Prevention
Pediatric Obesity
Eligibility:
All Genders
5-22 years
Brief Summary
Childhood obesity is a growing public health issue affecting millions of children worldwide, increasing the risk of metabolic and cardiovascular diseases in adulthood. This problem is particularly con...
Detailed Description
1. Study Design This is an observational cross-sectional study in which participants with T21, with and without obesity, will be evaluated without direct therapeutic intervention. 2. Registration ...
Eligibility Criteria
Inclusion
- Children (5-10 years), and adolescents (11-19) andyoung adults (20-22 years) of bothSexes
- 5 to 22 years old
- Diagnosis of trisomy 21 or other intellectual disability of genetic origin for the group of the cases.
- BMI: 17-40 Kg/m2
- Signing of the informed consent by the parents or guardians.
Exclusion
- Not meeting the inclusion criteria
- Have previous liver pathology.
- Be under any medical treatment that
- Modify composition parameters Body: GLP-1 analogues and derivatives.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2025
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT06888570
Start Date
March 1 2025
End Date
July 30 2025
Last Update
May 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fundación Jerome Lejeune
Madrid, Madrid, Spain